Innovating Works

SOGUG

DE-ESCALATE: INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHAS... GRUPO ESPANOL DE TRATAMIENTO DE TUMORES UROLOGICOS ASOCIACION participó en un HORIZON EUROPE HORIZON-MISS-2022-CANCER-01 Prostate Cancer is the most common cancer in European men. Despite dramatic improvements in early diagnostic and local treatment, one out of...
2023-04-21 - 2028-05-31 | Financiado
EUROTARGET: European collaborative project on Targeted therapy in renal cell cancer genetic and tumor related b... GRUPO ESPANOL DE TRATAMIENTO DE TUMORES UROLOGICOS ASOCIACION participó en un FP7 Each year more than 63,000 new cases of kidney cancer are diagnosed in the European Union. Approx. 50% of all patients have metastasized ren...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.